Related Experiment Videos
Inference for the cost-effectiveness acceptability curve and cost-effectiveness ratio
A O'Hagan1, J W Stevens, J Montmartin
1Statistical Services Unit, University of Sheffield, South Yorkshire, England. a.ohagan@sheffield.ac.uk
Pharmacoeconomics
|August 18, 2000
Summary
This study introduces simpler Bayesian and frequentist methods for cost-effectiveness (C/E) acceptability curves from clinical trials. The new approach accounts for variance uncertainty, offering more reliable inferences than standard methods.
Area of Science:
- Health economics
- Biostatistics
- Clinical trial analysis
Background:
- Cost-effectiveness (C/E) analysis is crucial for healthcare decision-making.
- Existing Bayesian methods for C/E acceptability curves often oversimplify variance estimation.
- Frequentist inference for C/E ratios can yield unreliable results.
Purpose of the Study:
- To present simplified Bayesian and frequentist inference methods for C/E acceptability curves.
- To address limitations in current Bayesian approaches, particularly regarding variance uncertainty.
- To offer a more robust alternative to standard frequentist C/E ratio inference.
Main Methods:
- Development of a simple Bayesian computation for the C/E acceptability curve.
- Introduction of a frequentist analogue to the Bayesian method.
- Utilizing distributional assumptions that account for uncertainty in estimated variances.
Main Results:
- The proposed Bayesian computation is simpler and more accurate than existing methods.
- The frequentist analogue provides a reliable alternative for C/E ratio inference.
- The methods correctly incorporate uncertainty in variance estimation, unlike normal posterior assumptions.
Conclusions:
- The presented methods offer improved accuracy and simplicity for Bayesian and frequentist C/E acceptability curve analysis.
- Accounting for variance uncertainty is critical for reliable cost-effectiveness inference.
- A Bayesian interval is recommended over standard frequentist procedures for C/E ratio inference.